CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported by the expansion to 48 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback